Transcatheter Aortic Valve Replacement
From index TAVR to valve-in-valve
Navigating the challenges of TAVR from index to valve-in-valve can feel overwhelming. That’s why Materialise Mimics for Cardiac Interventions, empowered by FEOPs' predictive insights, are designed to support you every step of the way. With advanced insights and precision tools, you can deliver safer, personalized care and achieve optimal outcomes — even in the most complex cases.
Confident decisions, demonstrated outcomes
Lifetime management
FEops’ predictive simulations offer valuable insights for current TAVR procedures and long-term planning, enabling evaluation of future valve-in-valve procedures and assessment of coronary access for potential redo-TAVR interventions. These tools support enhanced patient management beyond the current procedure.
35% of cases benefit from strategy changes
Clinical studies using FEops predictive simulations for TAVR show measurable impacts on procedural strategy, with 23% changes in device positioning and 12% changes in device size. These insights support favorable outcomes, empowering interventional cardiologists to make confident, data-driven decisions customized to each patient’s anatomy
Save up to 91% of time
Research demonstrates time-savings of up to 91% through AI-powered, automated 3D analysis of patient anatomy. Our intuitive TAVR software allows interactive adjustments and streamlines workflows, helping clinicians and the Heart Team achieve precision and efficiency without compromising control.
Increase confidence
Benefit from accurate prediction of TAVR device deformation, apposition, areas of contact and coronary access measurements by relying on accurate predictions.
Clinical evidence
Discover how our predictive simulations have been clinically researched, involving nearly 2,000 patients and over 260 validation cases. Here’s a glimpse into the science driving improved outcomes.
Simulations can give insights for lifetime management and support planning of redo-TAVI procedures
Patient-Specific Computer Modeling to Guide Redo Transcatheter Aortic valve replacement (2023)
Using FEops HEARTguide changed the procedural strategy in 35% of the cases. Excellent clinical outcomes were achieved for PVL and pacemaker implants.
Clinical Value Of CT-Derived Simulations Of Transcatheter-Aortic-Valve-Replacement In Challenging Anatomies: the PRECISE-TAVR Trial (2023)
There is a high correlation between frame deformation prediction, PVL prediction, and conduction abnormalities prediction. Patient-specific simulations might help predict the development of important clinical outcomes.
Patient-Specific Computer Simulation of Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Morphology (2019)
Clinical data report
Clinical data showcases the impact and reliability of our technologies. Data from TAVR and LAAO procedures demonstrate improved outcomes, efficiency, and physician confidence throughout the care pathway.
Related products and services
Online case planning assistance for complex structural heart procedures
Experience effortless online storage and case sharing with this cloud-based collaboration platform.
Start and scale a sustainable 3D printing lab at your hospital with confidence
3D-printed cardiovascular models
Accelerate your journey to personalization at scale with the most robust software platform for analysis, planning, and design.
Browse inspiring stories and resources
Discover how others benefit from our structural heart solutions
L-104629-01
Materialise Mimics and FEops’ predictive simulations are part of a continuously evolving technology platform. Some clinical evidence referenced in this content may have been generated using earlier versions of the software with capabilities that differ from the current release.
Materialise medical device software may not be available in all markets because product availability is subject to the regulatory or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.